116 related articles for article (PubMed ID: 8652258)
21. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
22. Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate.
Kleer CG; Michael CW
Diagn Cytopathol; 2000 Jul; 23(1):39-42. PubMed ID: 10907931
[TBL] [Abstract][Full Text] [Related]
23. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
[TBL] [Abstract][Full Text] [Related]
24. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
25. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
26. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
[TBL] [Abstract][Full Text] [Related]
27. The prognostic importance of syncytial growth pattern in medullary carcinoma of the breast.
Pedersen L; Schiødt T; Holck S; Zedeler K
APMIS; 1990 Oct; 98(10):921-6. PubMed ID: 2245011
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of breast cancer in relation to age.
Fisher CJ; Egan MK; Smith P; Wicks K; Millis RR; Fentiman IS
Br J Cancer; 1997; 75(4):593-6. PubMed ID: 9052416
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Tamiolakis D; Simopoulos C; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Papadopoulos N
Eur J Gynaecol Oncol; 2002; 23(5):433-6. PubMed ID: 12440819
[TBL] [Abstract][Full Text] [Related]
30. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
31. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
32. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
33. [Medullary carcinoma of the breast. What remains of this entity today?].
Contesso G; Rapin-Marion V; Mouriesse H
Arch Anat Cytol Pathol; 1995; 43(1-2):44-50. PubMed ID: 7794026
[TBL] [Abstract][Full Text] [Related]
34. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
35. HER2 as a prognostic factor in breast cancer.
Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
37. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.
Gaffey MJ; Mills SE; Frierson HF; Zarbo RJ; Boyd JC; Simpson JF; Weiss LM
Mod Pathol; 1995 Jan; 8(1):31-8. PubMed ID: 7731939
[TBL] [Abstract][Full Text] [Related]
38. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
39. DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Pedersen L; Larsen JK; Christensen IJ; Lykkesfeldt A; Holck S; Schiødt T
Breast Cancer Res Treat; 1994; 29(3):297-306. PubMed ID: 8049463
[TBL] [Abstract][Full Text] [Related]
40. Histological and immunohistochemical features of medullary breast cancer.
Romaniuk A; Lyndin M; Sikora V; Lyndina Y; Panasovska K
Folia Med Cracov; 2015; 55(2):41-8. PubMed ID: 26839242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
